ZzFTNCPcwC rUMXlc zTKmjg

Author: Jasmine Riviere Marcelin, MD

Follow @UNMC_ID at #IDWEEK2018!

IDWeek is here and we want to be sure YOU know where to find us! Below is the list of faculty presentations and posters from our Division. Please come visit us at IDWeek –  We would LOVE to meet you!  Content courtesy of Sandy Nelson and the entire UNMC ID Division.  Tuesday, October 2 Session: […]

Oct 2, 2018

Intensive Infection Control experience for UNMC ID Fellows

The Nebraska Medicine Infection Control and Epidemiology Department (IC&E) is well recognized for excellence. The department is staffed by 5 full-time Infection Preventionists (IP), a data analyst, and a staff assistant; Terry Michaels, manages the department. Dr. Rupp serves as the Medical Director and is assisted by Drs. Ashraf, Cawcutt, Marcelin, and VanSchooneveld as Associate […]

Oct 1, 2018

Allergy Emancipation

The following was originally posted to the Controversies in Hospital Infection Prevention Blog on 9/24/18 by Dr. Marcelin. September 28, 2018 marks 90 years since Sir Alexander Fleming discovered penicillin as an effective antimicrobial which would soon save millions of lives. He warned soon afterwards that unless we used penicillin judiciously, we would see antibiotic […]

Sep 28, 2018

UNMC ID Division Accolades!

Our Faculty at University of Nebraska Medical Center Division of Infectious Diseases have worked hard to maintain a strong academic presence at UNMC. We are a growing division, filled with faculty at all stages of their careers, and their collective academic prowess has our division leading the pack.  We are proud of our faculty and […]

Sep 24, 2018

CRE or not CRE: A Question of Risky Business and Notes from the Field

The following was originally posted by Dr. Marcelin to the August 2018 SHEA Journal Club  Carbapenem-resistant Enterobacteriaceae (CRE) are not as prevalent in the United States as they are in the Eastern Hemisphere; however travel within our global village means creates opportunity for movement of these organisms to our region.  The following is a review of […]

Sep 21, 2018

NBU

Are we ready for an outbreak?

It has been said that ‘an outbreak anywhere is a risk everywhere’.   At any given time, there are multiple concurrent outbreaks of highly hazardous communicable diseases, and the ease of global travel creates the risk of rapid spread of diseases around the world.  The Nebraska Biocontainment Unit (NBU) closely and continuously monitors these outbreaks, since […]

Sep 10, 2018

At UNMC, ID fellows learn HIV from the experts

Over the course of their training, fellows in the UNMC’s Division of Infectious Diseases will receive dedicated clinical and didactic training in the area of HIV alongside faculty with expertise in the HIV clinical care and research. Clinical Training: Fellows will have their continuity clinic at UNMC’s HIV clinic one half day each week. The […]

Aug 30, 2018

Are you a Pharmacist interested in an Infectious Diseases Clinical Practice? UNMC ID has the perfect job for you!

The Department of Pharmaceutical and Nutrition Care at Nebraska Medicine and the Division of Infectious Diseases at the University of Nebraska Medical Center (UNMC) are recruiting for a full-time clinical pharmacist to expand the Antimicrobial Stewardship Program and develop an Outpatient Parenteral Antimicrobial Therapy (OPAT) program in collaboration with a new Orthopedic Infectious Diseases service […]

Aug 27, 2018

Travels, Bones and Bugs, Oh My! ID fellows will see it all at UNMC

At UNMC ID we are fortunate to have some very unique experiences for fellows to explore their interests in our various aspects of our specialty. We are also fortunate to have experts and leaders at the helm, leading fellows through these experiences toward their ultimate career choices. One of these leaders is Dr. Angela Hewlett […]

Aug 22, 2018

Ceftazidime-avibactam resistance in carbapenem-resistant Enterobacteriaceae: what’s next on the horizon?

Ceftazidime-avibactam is approved by the Food & Drug Administration (FDA) for treatment of complicated intra-abdominal and urinary tract infections, and has activity against carbapenem-resistant Enterobacteriaceae (CRE). Data regarding its real-world application and potential pitfalls is still emerging, and this review illustrates some experiences with use and emerging resistance to ceftazidime-avibactam. The authors of the first […]

Aug 15, 2018